Apnimed
PulseAugur coverage of Apnimed — every cluster mentioning Apnimed across labs, papers, and developer communities, ranked by signal.
- 2026-07-31 funding Apnimed raised $192 million in an upsized IPO, valuing the company at over $600 million. source
2 day(s) with sentiment data
-
Eli Lilly's Obesity Drugs Fuel 48% Revenue Growth, Retatrutide Trials Show Promise
Eli Lilly and Company reported a significant increase in its second-quarter revenue, reaching $23 billion, a 48% year-over-year growth. This surge was primarily driven by its GLP-1 drugs, Mounjaro and Zepbound, which ge…
-
Apnimed raises $192M in IPO for sleep apnea pill
Apnimed, a biotech startup developing a pill for sleep apnea, has successfully raised $192 million in an upsized Initial Public Offering (IPO). The company's shares are set to trade on the Nasdaq, with the IPO valuing A…
-
Genesis AI partners with Incyte in $120M drug discovery deal
Genesis Molecular AI has secured a significant partnership with Incyte, a global biotech company, valued at $120 million. This deal includes $80 million in upfront cash and a $40 million equity investment, with potentia…